CD4 and neoplasm: Tumor-infiltrating lymphocytes (TILs) include CD8+ T cells and CD4+ T cells, for example, are unique independent prognostic markers for UVM patients and play essential roles in tumor recurrence, metastasis, dissemination, and responsiveness to immunotherapy (33–35).